Prestige Consumer Healthcare (PBH) Other financing activities (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Other financing activities of $752000.0 for Q3 2025, down 53.49% year-over-year from $1.6 million in Q3 2024, and down 76.16% quarter-over-quarter from $3.2 million in Q2 2025.
Prestige Consumer Healthcare (PBH) Other financing activities (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Other financing activities history runs 16 years deep, the most recent figure standing at $752000.0 for Q3 2025.
- In Q3 2025, Other financing activities fell 53.49% year-over-year to $752000.0; the TTM figure through Dec 2025 stood at $18.7 million (down 4.6% YoY), while the FY2025 annual figure was $14.8 million, down 18.17% from the prior year.
- Other financing activities for Q3 2025 stood at $752000.0, down from $3.2 million in the prior quarter.
- The five-year high for Other financing activities was $14.8 million in Q1 2025, with the low at $199000.0 in Q1 2023.
- The 5-year median for Other financing activities is $2.1 million (2023), against an average of $3.6 million.
- The sharpest annual moves came in 2021 and 2022: Other financing activities soared 7620.51% in 2021, then sank 74.26% in 2022.
- Prestige Consumer Healthcare's Other financing activities stood at $3.0 million in 2021, then jumped by 88.77% to $5.7 million in 2022, then plunged by 71.24% to $1.6 million in 2023, then jumped by 435.05% to $8.7 million in 2024, then sank by 91.4% to $752000.0 in 2025.
- Business Quant data shows PBH's Other financing activities at $752000.0 in Q3 2025, $3.2 million in Q2 2025, and $14.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Prestige Consumer Healthcare | 2.46 Bn | 2.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 752,000.00 |
| Sep 30, 2025 | 752,000.00 |
| Jun 30, 2025 | 3.16 Mn |
| Jun 30, 2025 | 3.16 Mn |
| Mar 31, 2025 | 14.80 Mn |
| Mar 31, 2025 | 14.80 Mn |
| Dec 31, 2024 | 8.75 Mn |
| Dec 31, 2024 | 8.75 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 1.98 Mn |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | 7.27 Mn |
| Mar 31, 2024 | 7.27 Mn |
| Dec 31, 2023 | 1.64 Mn |
| Dec 31, 2023 | 1.64 Mn |
| Sep 30, 2023 | 2.16 Mn |
| Sep 30, 2023 | 2.16 Mn |
| Jun 30, 2023 | 7.03 Mn |
| Jun 30, 2023 | 7.03 Mn |